Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can ...
Prostate cancer has become the most commonly diagnosed cancer in England, according to new analysis.
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...
Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.
News Medical on MSN8d
Study highlights potential of genomic tests for early stage prostate cancerA new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...
BBC presenter Nick Owen says famous people talking about prostate cancer has helped to raise awareness of the illness, with ...
Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback